Neil Tenenholtz

Neil Tenenholtz

Auto-generated profile, based on publicly available information

Neil Tenenholtz

Society of Imaging Informatics in Medicine, Leesburg, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EVEugene Vorontsov
Eugene Vorontsov
ABAlican Bozkurt
Alican Bozkurt
ACAdam Casson
Adam Casson
GSGeorge Shaikovski
George Shaikovski
MZMichal Zelechowski
Michal Zelechowski
TFThomas J. Fuchs
Thomas J. Fuchs
The analysis of histopathology images with artificial intelligence aims to enable clinical decision support systems and precision medicine. The success of such applications depends on the ability to model the diverse patterns observed in pathology images. To this end, we present Virchow, the largest foundation model for computational pathology to date. In addition to the evaluation of biomarker prediction and cell identification, we demonstrate that a large foundation model enables pan-cancer detection, achieving 0.95 specimen-level area under the (receiver operating characteristic) curve across nine common and seven rare cancers. Furthermore, we show that with less training data, the pan-cancer detector built on Virchow can achieve similar performance to tissue-specific clinical-grade models in production and outperform them on some rare variants of cancer. Virchow’s performance gains highlight the value of a foundation model and open possibilities for many high-impact applications with limited amounts of labeled training data.

12 September 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SASarah Alamdari
Sarah Alamdari
NTNitya Thakkar
Nitya Thakkar
RBRianne van Den Berg
Rianne van Den Berg
NTNeil Tenenholtz
Neil Tenenholtz
RSRobert Strome
Robert Strome
KYKevin K. Yang
Kevin K. Yang
Deep generative models are increasingly powerful tools for the in silico design of novel proteins. Recently, a family of generative models called diffusion models has demonstrated the ability to generate biologically plausible proteins that are dissimilar to any actual proteins seen in nature, enabling unprecedented capability and control in de novo protein design. However, current state-of-the-art diffusion models generate protein structures, which limits the scope of their training data and restricts generations to a small and biased subset of protein design space. Here, we introduce a general-purpose diffusion framework, EvoDiff, that combines evolutionary-scale data with the distinct conditioning capabilities of diffusion models for controllable protein generation in sequence space. EvoDiff generates high-fidelity, diverse, and structurally-plausible proteins that cover natural sequence and functional space. We show experimentally that EvoDiff generations express, fold, and exhibit expected secondary structure elements. Critically, EvoDiff can generate proteins inaccessible to structure-based models, such as those with disordered regions, while maintaining the ability to design scaffolds for functional structural motifs. We validate the universality of our sequence-based formulation by experimentally characterizing intrinsically-disordered mitochondrial targeting signals, metal-binding proteins, and protein binders designed using EvoDiff. We envision that EvoDiff will expand capabilities in protein engineering beyond the structure-function paradigm toward programmable, sequence-first design.

10 October 2019
Verified
Book Chapter
Closed access
PDF file
JLJen-Tang Lu
Jen-Tang Lu
RBRupert Brooks
Rupert Brooks
SHStefan Hahn
Stefan Hahn
JCJin Chen
Jin Chen
VBVarun Buch
Varun Buch
NTNeil A. Tenenholtz
Neil A. Tenenholtz

25 July 2025 in bioRxiv
Verified
Preprint
Open access
KYKevin K Yang
Kevin K Yang
SASarah Alamdari
Sarah Alamdari
ALAlex Lee
Alex Lee
KKKaeli Kaymak-Loveless
Kaeli Kaymak-Loveless
SCSamir Char
Samir Char
AAAva Pardis Amini
Ava Pardis Amini
Modern biology is powered by the organization of biological information, a framework pioneered in 1965 by Margaret Dayhoff's Atlas of Protein Sequence and Structure. Databases descended from this common ancestor power computational methods that have revolutionized our ability to understand and design proteins. We introduce the Dayhoff Atlas, a centralized collection of both protein sequence data and generative protein language models, as a modern-day resource for protein biology in the age of AI. We combined and reclustered metagenomic sequences with UniRef100 to create GigaRef, which includes 3.34 billion protein sequences across 1.70 billion clusters and provides the largest open dataset of natural proteins to date. To fuse the richness of protein structure with the scalability of sequence space, we generated structure-based synthetic data, producing BackboneRef, a first-in-class dataset of 46 million synthetic protein sequences predicted from 240,811 de novo designed backbones. Using these data and evolutionary sequence alignments, we trained the Dayhoff family of protein language models, including the first model that combines single proteins and sets of evolutionarily-related sequences at scale. Operating only in amino acid sequence space, the Dayhoff models can natively predict mutation effects on fitness, scaffold structural motifs, and perform guided generation of new proteins within a specific family. Learning from metagenomic and structure-based synthetic data from the Dayhoff Atlas increased the cellular expression rates of generated proteins, highlighting the real-world value of expanding the scale, diversity, and novelty of protein sequence data. We release the Dayhoff Atlas, including all datasets, code, and models, under a permissive license to continue to bring the power of computation to protein biology and design.

1 October 2025 in Medical Physics
Verified
Journal Article
Open access
FKFelipe Kitamura
Felipe Kitamura
TKTimothy Kline
Timothy Kline
DWDaniel Warren
Daniel Warren
LMLinda Moy
Linda Moy
RDRoxana Daneshjou
Roxana Daneshjou
NTNeil Tenenholtz
Neil Tenenholtz
Medical imaging is undergoing a transformation driven by the advent of new, highly effective, machine learning techniques paired with increases in computational capabilities (Cheng et al. 2021; Gilson et al. 2023; Almeida et al. 2024; Krishna et al. 2024). These advanced algorithms have the potential to improve disease detection, diagnosis, prognosis, and treatment outcomes. However, the complexity of machine learning models, the large amounts of curated and annotated data required by some methods, and the potential for bias and error make it challenging for individuals to safely and effectively leverage these methods (Lin et al. 2024; Guo et al. 2024; Xu et al. 2024; Linguraru et al. 2024; Wood et al. 2019). To address these challenges, the American Association of Physicists in Medicine (AAPM), American College of Radiology (ACR), Radiological Society of North America (RSNA), and Society for Imaging Informatics in Medicine (SIIM) have worked together to develop a syllabus detailing a recommended set of competencies for medical imaging professionals interacting with these systems. This guide is aimed at four different personas: users of AI systems, purchasers of AI systems, individuals who provide clinical expertise during the development of AI systems (“clinical collaborators”), and developers of AI systems.1 This is a syllabus, not a curriculum, and is intentional in this scope. Recognizing that individuals may benefit from different presentations of the same material, this work enumerates a series of relevant competencies but does not prescribe, nor offer, a method of instruction (Schuur, Rezazade Mehrizi, and Ranschaert 2021; Garin et al. 2023). By addressing the task‐specific demands of each role, this guide will enable medical imaging professionals to utilize machine learning systems more safely and effectively, ultimately improving patient care and outcomes.

31 July 2026 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EVEugene Vorontsov
Eugene Vorontsov
GSGeorge Shaikovski
George Shaikovski
ACAdam Casson
Adam Casson
JVJulian Viret
Julian Viret
EZEric Zimmermann
Eric Zimmermann
SLSiqi Liu
Siqi Liu
Recent rapid progress in the field of computational pathology has been enabled by foundation models. These models are beginning to move beyond encoding image patches toward whole-slide understanding, but their clinical utility remains limited. Here we present PRISM2, a multimodal slide-level foundation model trained on 2.3 million whole-slide images and 14 million question−answer pairs derived from 700,000 pathology reports. Through clinical dialogue supervision, PRISM2 aligns histomorphology with diagnostic reasoning, yielding representations that support both prompt-based inference and transferable embeddings for downstream tasks. With prompt-based inference, PRISM2 achieves or exceeds ( P < 0.05) the balanced accuracy of clinical-grade products calibrated for cancer detection in the prostate, breast and breast lymph node. Additionally, across comprehensive diagnostic, biomarker and survival benchmarks, PRISM2 embeddings never statistically underperform previous foundation models via linear probing ( P < 0.05). Furthermore, task-specific fine-tuning on survival prediction outperforms training from scratch on the same large survival dataset. PRISM2 demonstrates how language-supervised pretraining provides a scalable, clinically grounded signal for generalizable pathology representations, bridging human diagnostic reasoning and foundation model performance.